John C. Lechleiter

2013

In 2013, John C. Lechleiter earned a total compensation of $11.2M as Chairman, President, and Chief Executive Officer at Lilly Eli & Co, a 23% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$2,877,000
Salary$1,500,000
Stock Awards$6,750,000
Other$90,000
Total$11,217,000

Lechleiter received $6.8M in stock awards, accounting for 60% of the total pay in 2013.

Lechleiter also received $2.9M in non-equity incentive plan, $1.5M in salary and $90K in other compensation.

Rankings

In 2013, John C. Lechleiter's compensation ranked 315th out of 12,286 executives tracked by ExecPay. In other words, Lechleiter earned more than 97.4% of executives.

ClassificationRankingPercentile
All
315
out of 12,286
97th
Division
Manufacturing
97
out of 4,612
98th
Major group
Chemicals And Allied Products
27
out of 1,462
98th
Industry group
Drugs
19
out of 1,156
98th
Industry
Pharmaceutical Preparations
17
out of 890
98th
Source: SEC filing on March 21, 2016.

Lechleiter's colleagues

We found four more compensation records of executives who worked with John C. Lechleiter at Lilly Eli & Co in 2013.

2013

Derica Rice

Lilly Eli & Co

Chief Financial Officer

2013

Jan Lundberg

Lilly Eli & Co

Executive Vice President, Science and Technology and President, Lilly Research Laboratories

2013

Michael Harrington

Lilly Eli & Co

General Counsel

2013

Enrique Conterno

Lilly Eli & Co

Senior Vice President and President Diabetes Business Unit

You may also like